Leiden University Medical Center clinical trial pipeline

7 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 4 with minor changes only.

1. Notable

   SynBioSe-2 · Synergetic B-cell Immunomodulation in SLE - 2nd Study

   Primary completion pushed from Jun 7, 2024 to Jun 22, 2026

   Also in this update: Trial completed

   Leiden University Medical Center·Phase 3· NCT03747159· Registry history of NCT03747159 on ClinicalTrials.gov (opens the registry)

   Oct 7, 2026

2. Notable

   RAINBO-GREEN · Refining Adjuvant Treatment IN Endometrial…RAINBO-GREEN · Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features

   Primary endpoint(s) modified

   Also in this update: Enrollment reduced: 1615 → 316 participants; Phase changed: Phase 2/3 → Phase 3

   Leiden University Medical Center·Phase 3· NCT05255653· Registry history of NCT05255653 on ClinicalTrials.gov (opens the registry)

   Oct 8, 2026

3. Notable

   BE-MOBILYZED · Belimumab to Mobilise Memory B-cells From…BE-MOBILYZED · Belimumab to Mobilise Memory B-cells From Secondary Lymhoid Organs to Improve Memory B-cell HLA-specificity Profiling to Support Delisting for Transplant Access in Highly-sensitized

   Recruitment opened

   Leiden University Medical Center·Phase 2· NCT07539857· Registry history of NCT07539857 on ClinicalTrials.gov (opens the registry)

   Sep 22, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.